Based in the United States, Versartis is a startup.
Versartis was a biopharmaceutical company developing long-acting growth hormone therapies, including somavaratan (VRS-317), for the treatment of growth hormone deficiency.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.